Company

Celadon Pharmaceuticals Plc

Headquarters: London, United Kingdom

Employees: 24

CEO: Mr. James Gareth Short

LSE: CEL -1.89%

Detailed Description

Celadon Pharmaceuticals Plc engages in the research, cultivation, manufacturing, and sale of cannabis-based medicines. The company primarily focuses on growing indoor hydroponic cannabis for use in medicinal products used to treat chronic pain, as well as autism spectrum disorders. Celadon Pharmaceuticals Plc was founded in 2018 and is headquartered in London, the United Kingdom.

Top 1-year algo backtest: +265.99%

$10,000 in October 2023 would now be $36,599 by following this algorithm daily at market close.

Use AI to boost your investing & swing trading, now!

Try Disfold DeepFinance FREE

Stocks & Indices

Celadon Pharmaceuticals Plc has the following listings and related stock indices.


Stock: LSE: CEL wb_incandescent

Details

Headquarters:

32-33 Cowcross Street

London, EC1M 6DF

United Kingdom

Phone: 44 20 3150 0252